The Global In-Vitro Fertilization Market Size accounted for USD 21.6 Billion in 2021 and is estimated to achieve a market size of USD 36.2 Billion by 2030 growing at a CAGR of 6.1% from 2022 to 2030. Growing male infertility, an increase in the median age of first-time mothers, growing obesity, diminishing fertility rates, with growing alcohol intake are driving the global in-vitro fertilization (IVF) market growth. Furthermore, increased awareness of infertility, combined with the accessibility of enhanced therapeutic approaches, is boosting the in-vitro fertilization market value.
In-Vitro Fertilization Market Report Key Highlights
- Global in-vitro fertilization market revenue is expected to increase by USD 36.2 billion by 2030, with a 6.1% CAGR from 2022 to 2030
- Europe region led with more than 37.4% of in-vitro fertilization market share in 2021
- Asia-Pacific in-vitro fertilization market growth will observe strongest CAGR from 2022 to 2030
- By instrument, the culture media segment has accounted market share of over 42% in 2021
- By type, frozen non-donor segment engaged more than 46% of the total market share in 2021
- Rise in the prevalence of infertility, drives the in-vitro fertilization market size
In-Vitro Fertilization (IVF) is a type of assisted reproductive technique in which in laboratory environments the ovum is artificially fertilized and then implanted into the womb. IVF is one of the most common therapies used for infertility problems in pairs, single mothers, and the LGBT community.
Global In-Vitro Fertilization Market Trends
Market Drivers
- Rise in the prevalence of infertility across the globe
- Growing rate of obesity & increased alcohol consumption
- Increasing public awareness of the use of IVF treatments
- Increased infertility rates & embryo banking procedures
Market Restraints
- High cost of IVF treatment
- Inadequate regulatory framework and homogenous regulation
Market Opportunities
- Government programs to encourage IVF treatments
- Product development and technological advancement
In-Vitro Fertilization Market Report Coverage
Market |
In-Vitro Fertilization Market |
In-Vitro Fertilization Market Size 2021 |
USD 21.6 Billion |
In-Vitro Fertilization Market Forecast 2030 |
USD 36.2 Billion |
In-Vitro Fertilization Market CAGR During 2022 - 2030 |
6.1% |
In-Vitro Fertilization Market Analysis Period |
2018 - 2030 |
In-Vitro Fertilization Market Base Year |
2021 |
In-Vitro Fertilization Market Forecast Data |
2022 - 2030 |
Segments Covered |
By Instrument, By Type, By End-Use, And By Geography
|
Regional Scope |
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa |
Key Companies Profiled |
EMD Serono Inc., Genea Biomedx, Irvine Scientific, Cook Medical Inc., Boston IVF, OvaScience, Vitrolife AB, Thermo Fisher Scientific Inc., Cooper Surgical Inc., and Progyny, Inc.
|
Report Coverage
|
Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Regulation Analysis |
In-Vitro Fertilization Market Dynamics
The global in-vitro fertilization (IVF) market size is driven by an increase in infertility, the increase in the trend of delayed pregnancies, an increase in IVF success, and an increase in available earnings worldwide. However, higher costs, IVF-related complications, and low awareness of IVF in certain less-developed regions limit the growth of the in-vitro fertilization (IVF) market revenue.
Due to a risen infertility rate, a rise in delayed pregnancies, an increase in IVF success rate, and a worldwide rise in disposable revenues, the global IVF market value is expected to grow significantly during this period. In some developing regions, the growth of the IVF service market is hampered by high costs, IVF-related complications, and low IVF awareness. Inverse, the growth of fertility tourism, increased fertility clinics and the potential for growth in emerging markets will make way for the development of the IVF services market in the future.
Most IVF requirements are imported in developing African regions and can only be used once in each cycle. The incidence of infertility in Nigeria is about 25% compared with 1015% in the United States and the UK, according to the University of Benin (Nigeria). IVF procedures helped couples manage these high levels of infertility. The low cost of IVF therapy and the rise in fertility tourism trends in South Africa continue to drive Africa's in vitro market growth. On the other hand, lack of funding, poor income, insufficient awareness of IVF, inadequate coverage of health services, and lack of educated professionals impede growth in developing economies of Africa.
In-Vitro Fertilization Market Segmentation
The global in-vitro fertilization market segmentation is based on instrument, type, end-use, and geography.
In-Vitro Fertilization Market By Instrument
- Culture Media
- Disposable Devices
- Capital Equipment
According to an in-vitro fertilization industry analysis, the culture media instrument segment held the largest market share in 2021. This expansion was attributed to causes such as increased funding availability as well as a rise in research programs to improve culture media. However, as market players provide disposable equipment such as slides, needles, and chambers to fulfill sterility & regulatory standards, the disposable equipment category is predicted to develop at the quickest rate during the projection years.
In-Vitro Fertilization Market By Type
- Frozen Non-donor
- Fresh Non-donor
- Frozen Donor
- Fresh Donor
In terms of type, the frozen non-donor segment is anticipated to dominate the market in 2021. This is due to a variety of causes, including a high success rate, greater birth rates than frozen eggs, simple fertilization, as well as fresh egg retrievals leading to superior results. The increased use of the new non-donor cycle, combined with growing infertility rates around the world, is the main factor in this market. This cycle's rising popularity is likely to maintain its domination throughout the predicted period.
In-Vitro Fertilization Market By End-Use
- Fertility Clinics
- Hospitals & others
According to the in-vitro fertilization market forecast, the hospital segment is predicted to increase significantly in the industry in the coming years. The extensive infiltration of hospitals, expanding digital infrastructure in emerging economies, the availability of health experts around the time, and the introduction of modern surgical technologies and innovations in health facilities are the key factors contributing to the growth of hospital services.
In-Vitro Fertilization Market Regional Outlook
North America
Europe
- U.K.
- Germany
- France
- Spain
- Rest of Europe
Asia-Pacific
- India
- Japan
- China
- Australia
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
The Middle East & Africa
- South Africa
- GCC Countries
- Rest of the Middle East & Africa (ME&A)
Europe Region Dominates and Asia-Pacific Is Expected To Grow Significantly In Market in the Coming Years
Geographically, Europe is expected to dominate the market in 2021. Increasing medical tourism and legislation modifications connected to IVF treatments will drive regional market expansion in the projected timeframe. Additionally, the Asia-Pacific region is predicted to grow at a rapid pace during the projection period. This is due to a large population, rapidly dropping fertility rates, a spike in the amount of women-focused federal programs, a growing choice for jobs over families among women, and more understanding about fertility clinics & treatments. Growing public awareness of in-vitro fertilization, increasing healthcare spending, and expanding use of sophisticated reproductive technology in Asia-Pacific are major factors of the in-vitro fertilization market.
In-Vitro Fertilization Market Players
Some of the top in-vitro fertilization market companies offered in the professional report includes EMD Serono Inc., Genea Biomedx, Irvine Scientific, Cook Medical Inc., Boston IVF, OvaScience, Vitrolife AB, Thermo Fisher Scientific Inc., Cooper Surgical Inc., and Progyny, Inc.
CHAPTER 1. Industry Overview of In-Vitro Fertilization Market
1.1. Definition and Scope
1.1.1. Definition of In-Vitro Fertilization
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global In-Vitro Fertilization Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. In-Vitro Fertilization Market By Instrument
1.2.3. In-Vitro Fertilization Market By Type
1.2.4. In-Vitro Fertilization Market By End-Use
1.2.5. In-Vitro Fertilization Market By Region
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data End-Use
2.2.1. Secondary Source
2.2.2. Primary Source
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of In-Vitro Fertilization Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for In-Vitro Fertilization Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Regulatory Compliance
3.9. Competitive Landscape, 2021
3.9.1. Player Positioning Analysis
3.9.2. Key Strategies Adopted By Leading Players
CHAPTER 4. In-Vitro Fertilization Market By Instrument
4.1. Introduction
4.2. In-Vitro Fertilization Revenue By Instrument
4.2.1. In-Vitro Fertilization Revenue (USD Billion) and Forecast, By Instrument, 2018-2030
4.2.2. Culture Media
4.2.2.1. Culture Media Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
4.2.3. Disposable Devices
4.2.3.1. Disposable Devices Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
4.2.4. Capital Equipment
4.2.4.1. Capital Equipment Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
CHAPTER 5. In-Vitro Fertilization Market By Type
5.1. Introduction
5.2. In-Vitro Fertilization Revenue By Type
5.2.1. In-Vitro Fertilization Revenue (USD Billion) and Forecast, By Type, 2018-2030
5.2.2. Frozen Non-donor
5.2.2.1. Frozen Non-donor Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
5.2.3. Fresh Non-donor
5.2.3.1. Fresh Non-donor Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
5.2.4. Frozen Donor
5.2.4.1. Frozen Donor Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
5.2.5. Fresh Donor
5.2.5.1. Fresh Donor Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
CHAPTER 6. In-Vitro Fertilization Market By End-Use
6.1. Introduction
6.2. In-Vitro Fertilization Revenue By End-Use
6.2.1. In-Vitro Fertilization Revenue (USD Billion) and Forecast, By End-Use, 2018-2030
6.2.2. Fertility Clinics
6.2.2.1. Fertility Clinics Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
6.2.3. Hospitals & Others
6.2.3.1. Hospitals & Others Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
CHAPTER 7. North America In-Vitro Fertilization Market By Country
7.1. North America In-Vitro Fertilization Market Overview
7.2. U.S.
7.2.1. U.S. In-Vitro Fertilization Revenue (USD Billion) and Forecast By Instrument, 2018-2030
7.2.2. U.S. In-Vitro Fertilization Revenue (USD Billion) and Forecast By Type, 2018-2030
7.2.3. U.S. In-Vitro Fertilization Revenue (USD Billion) and Forecast By End-Use, 2018-2030
7.3. Canada
7.3.1. Canada In-Vitro Fertilization Revenue (USD Billion) and Forecast By Instrument, 2018-2030
7.3.2. Canada In-Vitro Fertilization Revenue (USD Billion) and Forecast By Type, 2018-2030
7.3.3. Canada In-Vitro Fertilization Revenue (USD Billion) and Forecast By End-Use, 2018-2030
7.4. North America PEST Analysis
CHAPTER 8. Europe In-Vitro Fertilization Market By Country
8.1. Europe In-Vitro Fertilization Market Overview
8.2. U.K.
8.2.1. U.K. In-Vitro Fertilization Revenue (USD Billion) and Forecast By Instrument, 2018-2030
8.2.2. U.K. In-Vitro Fertilization Revenue (USD Billion) and Forecast By Type, 2018-2030
8.2.3. U.K. In-Vitro Fertilization Revenue (USD Billion) and Forecast By End-Use, 2018-2030
8.3. Germany
8.3.1. Germany In-Vitro Fertilization Revenue (USD Billion) and Forecast By Instrument, 2018-2030
8.3.2. Germany In-Vitro Fertilization Revenue (USD Billion) and Forecast By Type, 2018-2030
8.3.3. Germany In-Vitro Fertilization Revenue (USD Billion) and Forecast By End-Use, 2018-2030
8.4. France
8.4.1. France In-Vitro Fertilization Revenue (USD Billion) and Forecast By Instrument, 2018-2030
8.4.2. France In-Vitro Fertilization Revenue (USD Billion) and Forecast By Type, 2018-2030
8.4.3. France In-Vitro Fertilization Revenue (USD Billion) and Forecast By End-Use, 2018-2030
8.5. Spain
8.5.1. Spain In-Vitro Fertilization Revenue (USD Billion) and Forecast By Instrument, 2018-2030
8.5.2. Spain In-Vitro Fertilization Revenue (USD Billion) and Forecast By Type, 2018-2030
8.5.3. Spain In-Vitro Fertilization Revenue (USD Billion) and Forecast By End-Use, 2018-2030
8.6. Rest of Europe
8.6.1. Rest of Europe In-Vitro Fertilization Revenue (USD Billion) and Forecast By Instrument, 2018-2030
8.6.2. Rest of Europe In-Vitro Fertilization Revenue (USD Billion) and Forecast By Type, 2018-2030
8.6.3. Rest of Europe In-Vitro Fertilization Revenue (USD Billion) and Forecast By End-Use, 2018-2030
8.7. Europe PEST Analysis
CHAPTER 9. Asia Pacific In-Vitro Fertilization Market By Country
9.1. Asia Pacific In-Vitro Fertilization Market Overview
9.2. China
9.2.1. China In-Vitro Fertilization Revenue (USD Billion) and Forecast By Instrument, 2018-2030
9.2.2. China In-Vitro Fertilization Revenue (USD Billion) and Forecast By Type, 2018-2030
9.2.3. China In-Vitro Fertilization Revenue (USD Billion) and Forecast By End-Use, 2018-2030
9.3. Japan
9.3.1. Japan In-Vitro Fertilization Revenue (USD Billion) and Forecast By Instrument, 2018-2030
9.3.2. Japan In-Vitro Fertilization Revenue (USD Billion) and Forecast By Type, 2018-2030
9.3.3. Japan In-Vitro Fertilization Revenue (USD Billion) and Forecast By End-Use, 2018-2030
9.4. India
9.4.1. India In-Vitro Fertilization Revenue (USD Billion) and Forecast By Instrument, 2018-2030
9.4.2. India In-Vitro Fertilization Revenue (USD Billion) and Forecast By Type, 2018-2030
9.4.3. India In-Vitro Fertilization Revenue (USD Billion) and Forecast By End-Use, 2018-2030
9.5. Australia
9.5.1. Australia In-Vitro Fertilization Revenue (USD Billion) and Forecast By Instrument, 2018-2030
9.5.2. Australia In-Vitro Fertilization Revenue (USD Billion) and Forecast By Type, 2018-2030
9.5.3. Australia In-Vitro Fertilization Revenue (USD Billion) and Forecast By End-Use, 2018-2030
9.6. South Korea
9.6.1. South Korea In-Vitro Fertilization Revenue (USD Billion) and Forecast By Instrument, 2018-2030
9.6.2. South Korea In-Vitro Fertilization Revenue (USD Billion) and Forecast By Type, 2018-2030
9.6.3. South Korea In-Vitro Fertilization Revenue (USD Billion) and Forecast By End-Use, 2018-2030
9.7. Rest of Asia-Pacific
9.7.1. Rest of Asia-Pacific In-Vitro Fertilization Revenue (USD Billion) and Forecast By Instrument, 2018-2030
9.7.2. Rest of Asia-Pacific In-Vitro Fertilization Revenue (USD Billion) and Forecast By Type, 2018-2030
9.7.3. Rest of Asia-Pacific In-Vitro Fertilization Revenue (USD Billion) and Forecast By End-Use, 2018-2030
9.8. Asia Pacific PEST Analysis
CHAPTER 10. Latin America In-Vitro Fertilization Market By Country
10.1. Latin America In-Vitro Fertilization Market Overview
10.2. Brazil
10.2.1. Brazil In-Vitro Fertilization Revenue (USD Billion) and Forecast By Instrument, 2018-2030
10.2.2. Brazil In-Vitro Fertilization Revenue (USD Billion) and Forecast By Type, 2018-2030
10.2.3. Brazil In-Vitro Fertilization Revenue (USD Billion) and Forecast By End-Use, 2018-2030
10.3. Mexico
10.3.1. Mexico In-Vitro Fertilization Revenue (USD Billion) and Forecast By Instrument, 2018-2030
10.3.2. Mexico In-Vitro Fertilization Revenue (USD Billion) and Forecast By Type, 2018-2030
10.3.3. Mexico In-Vitro Fertilization Revenue (USD Billion) and Forecast By End-Use, 2018-2030
10.4. Rest of Latin America
10.4.1. Rest of Latin America In-Vitro Fertilization Revenue (USD Billion) and Forecast By Instrument, 2018-2030
10.4.2. Rest of Latin America In-Vitro Fertilization Revenue (USD Billion) and Forecast By Type, 2018-2030
10.4.3. Rest of Latin America In-Vitro Fertilization Revenue (USD Billion) and Forecast By End-Use, 2018-2030
10.5. Latin America PEST Analysis
CHAPTER 11. Middle East & Africa In-Vitro Fertilization Market By Country
11.1. Middle East & Africa In-Vitro Fertilization Market Overview
11.2. GCC
11.2.1. GCC In-Vitro Fertilization Revenue (USD Billion) and Forecast By Instrument, 2018-2030
11.2.2. GCC In-Vitro Fertilization Revenue (USD Billion) and Forecast By Type, 2018-2030
11.2.3. GCC In-Vitro Fertilization Revenue (USD Billion) and Forecast By End-Use, 2018-2030
11.3. South Africa
11.3.1. South Africa In-Vitro Fertilization Revenue (USD Billion) and Forecast By Instrument, 2018-2030
11.3.2. South Africa In-Vitro Fertilization Revenue (USD Billion) and Forecast By Type, 2018-2030
11.3.3. South Africa In-Vitro Fertilization Revenue (USD Billion) and Forecast By End-Use, 2018-2030
11.4. Rest of Middle East & Africa
11.4.1. Rest of Middle East & Africa In-Vitro Fertilization Revenue (USD Billion) and Forecast By Instrument, 2018-2030
11.4.2. Rest of Middle East & Africa In-Vitro Fertilization Revenue (USD Billion) and Forecast By Type, 2018-2030
11.4.3. Rest of Middle East & Africa In-Vitro Fertilization Revenue (USD Billion) and Forecast By End-Use, 2018-2030
11.5. Middle East & Africa PEST Analysis
CHAPTER 12. Player Analysis Of In-Vitro Fertilization Market
12.1. In-Vitro Fertilization Market Company Share Analysis
12.2. Competition Matrix
12.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
12.2.2. New Product Launches and Product Enhancements
12.2.3. Mergers And Acquisition In Global In-Vitro Fertilization Market
12.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 13. Company Profile
13.1. EMD Serono Inc.
13.1.1. Company Snapshot
13.1.2. Business Overview
13.1.3. Financial Overview
13.1.3.1. Revenue (USD Billion), 2021
13.1.3.2. EMD Serono Inc. 2021 In-Vitro Fertilization Business Regional Distribution
13.1.4. Product/Service and Specification
13.1.5. Recent Developments & Business Strategy
13.2. OvaScience
13.3. Genea Biomedx
13.4. Vitrolife AB
13.5. Irvine Scientific
13.6. Thermo Fisher Scientific Inc.
13.7. Cook Medical Inc.
13.8. Cooper Surgical Inc.
13.9. Boston IVF
13.10. Progyny, Inc.